| Patent application number | Description | Published |
|---|
| 20080255220 | Therapeutic Substituted Gamma Lactams - Disclosed herein is a compound comprising | 10-16-2008 |
| 20080269498 | THERAPEUTIC SUBSTITUTED LACTAMS - Therapeutic compounds, compositions, medicaments, and methods are disclosed herein. | 10-30-2008 |
| 20080300269 | THERAPEUTIC COMPOUNDS - Disclosed herein are compounds of the formula | 12-04-2008 |
| 20090018168 | THERAPEUTIC SUBSTITUTED CHLOROCYCLOPENTANOLS - Disclosed herein is a compound having a formula | 01-15-2009 |
| 20090054505 | THERAPEUTIC OXAZOLIDINONES AND THIAZOLIDINONES - Disclosed herein is a compound represented by a formula | 02-26-2009 |
| 20090062344 | THERAPEUTIC SUBSTITUTED PIPERIDONE COMPOUNDS - Compounds comprising | 03-05-2009 |
| 20090062361 | THERAPEUTIC HYDANTOINS - Disclosed herein is a compound represented by a formula | 03-05-2009 |
| 20090069309 | PROSTAGLANDIN ANALOGS - Compounds comprising | 03-12-2009 |
| 20090099249 | THERAPEUTIC LACTAMS - Disclosed herein is a compound having a structure | 04-16-2009 |
| 20090163560 | THERAPEUTIC N-ARYL OR N-HETEROARYL PYRAZOLIDINE AND PYRAZOLIDINONE DERIVATIVES - A compound having a structure | 06-25-2009 |
| 20090186866 | THERAPEUTIC BETA-LACTAMS - Compounds comprising | 07-23-2009 |
| 20090186885 | THERAPEUTIC COMPOUNDS - Disclosed herein is a compound according to one of the formulas | 07-23-2009 |
| 20090192151 | THERAPEUTIC AMIDES AND RELATED COMPOUNDS - Disclosed herein are compounds useful in treating glaucoma, inflammatory bowel disease, the stimulation of hair growth, and the stimulation of the conversion of vellus hair to terminal hair. The compounds themselves are herein. | 07-30-2009 |
| 20090192159 | SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS - Disclosed herein is a compound represented by the formula: | 07-30-2009 |
| 20090209538 | THERAPEUTIC SUBSTITUTED LACTAMS - Herein are described compounds having a structure | 08-20-2009 |
| 20090215740 | THERAPEUTIC SUBSTITUTED BETA-LACTAMS - A compound having a structure | 08-27-2009 |
| 20090239858 | THERAPEUTIC AMIDES - Compounds comprising | 09-24-2009 |
| 20090239867 | THERAPEUTIC SUBSTITUTED GAMMA LACTAMS - Disclosed herein is a compound comprising | 09-24-2009 |
| 20090247527 | SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS - A compound having the formula | 10-01-2009 |
| 20090247594 | THERAPEUTIC COMPOUNDS - Disclosed herein is a compound having a structure | 10-01-2009 |
| 20090270385 | SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS - Compounds comprising | 10-29-2009 |
| 20090270386 | THERAPEUTIC COMPOUNDS - Compounds comprising | 10-29-2009 |
| 20090270392 | SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS - Therapeutic compounds, compositions, medicaments, and methods are disclosed herein. | 10-29-2009 |
| 20090270396 | THERAPEUTIC COMPOUNDS - Compounds comprising | 10-29-2009 |
| 20090281101 | THERAPEUTIC SUBSTITUTED HYDANTOINS, AND RELATED COMPOUNDS - Compounds comprising a structure | 11-12-2009 |
| 20090281102 | THERAPEUTIC N-ARYL OR N-HETEROARYL PYRAZOLIDINE AND PYRAZOLIDINONE DERIVATIVES - Compounds comprising | 11-12-2009 |
| 20090281171 | THERAPEUTIC SUBSTITUTED THIAZOLIDINONES, OXAZOLIDINONES, AND RELATED COMPOUNDS - Compounds comprising | 11-12-2009 |
| 20090286787 | SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS - A compound comprising | 11-19-2009 |
| 20090318404 | SUBSTITUTED BETA-LACTAMS - Disclosed herein is a compound comprising | 12-24-2009 |
| 20090318449 | THERAPEUTIC LACTAMS - Compounds comprising | 12-24-2009 |
| 20100029735 | THERAPEUTIC COMPOUNDS - Disclosed herein is a compound of the formula. Therapeutic methods, compositions, and medicaments for the treatment of glaucoma or ocular hypertension related thereto are also disclosed. | 02-04-2010 |
| 20100048664 | THERAPEUTIC SUBSTITUTED PYRROLES - Disclosed herein is a compound represented by a formula: | 02-25-2010 |
| 20100048669 | THERAPEUTIC COMPOUNDS - Disclosed herein are compounds of the formula | 02-25-2010 |
| 20100093729 | SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS - A compound comprising or a pharmaceutically acceptable salt, prodrug, or a metabolite thereof is disclosed herein. Y, A, and B are as described herein. Methods, compositions, and medicaments related to these compounds are also disclosed. | 04-15-2010 |
| 20100093809 | THERAPEUTIC SUBSTITUTED THIAZOLIDINONES, OXAZOLIDINONES, AND RELATED COMPOUNDS - A compound having a structure | 04-15-2010 |
| 20100160407 | THERAPEUTIC SUBSTITUTED CYCLIC LACTAMS - Disclosed and described herein is a compound having a formula (I) therapeutic methods, medicaments, and compositions related thereto are also disclosed. | 06-24-2010 |
| 20100168189 | THERAPEUTIC SUBSTITUTED LACTAMS - Therapeutic compounds, compositions, methods, and medicaments related thereto are disclosed herein. | 07-01-2010 |
| 20100173981 | THERAPEUTIC COMPOUNDS - Disclosed herein is a compound according to one of the formulas or a pharmaceutically acceptable salt thereof, medicaments for the treatment of glaucoma or ocular hypertension and compositions related thereto, as further elaborated herein. | 07-08-2010 |
| 20100210689 | THERAPEUTIC SUBSTITUTED CHLOROCYCLOPENTANOLS - Disclosed herein is a compound having a formula | 08-19-2010 |
| 20100292293 | THERAPEUTIC SUBSTITUTED LACTAMS - Disclosed herein are compounds having a formula: (I) Compositions, methods, and medicaments related thereto are also disclosed. | 11-18-2010 |
| 20100317872 | THERAPEUTIC COMPOUNDS - A compound having a substituted five or six-membered carbocycle or heterocycle directly bonded to a substituted aryl or heteroaryl ring, wherein said compound has an EC | 12-16-2010 |
| 20110059939 | THERAPEUTIC COMPOUNDS - Compounds comprising formula (I) or a pharmaceutically acceptable salt thereof, a dashed line represent the presence or absence of a double bond, are disclosed, wherein J | 03-10-2011 |
| 20110059967 | THERAPEUTIC COMPOUNDS - Compounds comprising Formula (I) or a pharmaceutically acceptable salt thereof, are disclosed, wherein J | 03-10-2011 |
| 20110152328 | Combination Therapy For Glaucoma - Disclosed herein is method of treating glaucoma or ocular hypertension comprising administering a prostaglandin agonist and a second therapeutically active agent to a mammal in need thereof, wherein said second therapeutically active agent is selected from: β-Blockers, Adrenergic Agonists, non-selective adrenergic agonists, α2-selective adrenergic agonists, Carbonic Anhydrase Inhibitors, Cholinergic Agonists, direct acting cholinergic agonists, chlolinesterase inhibitors, Glutamate Antagonists, Ca | 06-23-2011 |
